Hledat
Psychoactive Substances
Psychoactive substances are natural or synthetic substances that act on the central nervous system and alter mental processes such as mood, perception, cognition, consciousness, and behaviour. These substances may be legally prescribed medications (e.g., pain medications or sedatives), legally available substances such as alcohol or caffeine, or controlled or illicit drugs. Psychoactive substances can be used for medical, social, cultural, or recreational purposes, but some carry risks of misuse, dependence, and health or social harms when used in harmful ways.
Substance Use in the LGBTQ+ Community: Reading List
Lesbian, Gay, Bisexual, Transgender and Queer (LGBTQ+) Pride month is celebrated each year during the month of June. Here you can find a list of resources and research on the topic of substance use among the LGBTQ+ community.
1) This repor...
European Drug Report 2023: Trends and Developments
The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national...
Treatment and Prevention of Substance Use Disorders in the Workplace
ISSUP Kenya present their webinar on Workplace Substance Use.
Family Day: NGO launches an information guide for parents
A l’occasion de la journée internationale de la famille, célébrée le 15 mai de chaque année, l’ONG RAPAA (Recherche Action Prévention Accompagnement des Addictions) a organisé une cérémonie de lancement d’un guide destiné aux familles...
MPSP se manifesta contra a descriminalização do porte de drogas para consumo pessoal
Dr. Mario Luiz Sarrubbo, Procurador-Geral da Justiça do Estado de São Paulo, protocolizou um memorial no Supremo Tribunal Federal – STF com o posicionamento do Ministério Público paulista sobre a pauta que trata da possível...
Increase in driving after cocaine use in Spain: a cross-sectional dataset analysis for 2021
Objective: Driving under the influence of alcohol and/or drugs impairs skills essential for safe driving, increases the risk of being involved in a traffic accident and is particularly prevalent in Spain. The aim is to assess the prevalence...
Účinky kouření konopí u školní mládeže
ISSUP Chile představil webinář na téma "Účinky užívání kouřeného konopí u školní mládeže".
Snížení stigmatizace lidí žijících s HIV a lidí, kteří si drogy aplikují nitrožilně
Navzdory rozsáhlým důkazům o negativních účincích stigmatu, které zažívají lidé žijící s HIV (PLHIV) a lidé, kteří si drogy aplikují injekčně ve zdravotnických zařízeních, existuje poměrně málo důkazů o účinnosti iniciativ na snížení tohoto...
Spotřeba psychoaktivních látek ve vzorcích guatemalské školní populace
Byl proveden výzkum sestávající ze 4 magisterských absolventských prací se smíšenou popisnou metodikou, které se zabývají různými rizikovými faktory, které způsobují studentům v Guatemale, kteří spadají do problémů užívání, spotřeby a...
Treatment for drug and alcohol misuse should involve families and communities
Alcohol and other drug treatment are generally only provided for individuals, often away from their families. Treatment aims to improve well-being and reduce the harms of substance use and families and communities can play a significant...
Dospívající a užívání návykových látek - co mohou rodiče dělat?
Cíl: Pomoci dospělým zvládat rizika spojená s užíváním návykových látek dospívajícími v souladu se zásadami prevence založenými na důkazech.
Pozadí: Kouření a pití mezi studenty ve věku 15–16 let vykazuje známky poklesu, ale existují...
Understanding the risks of mixing drugs
February 17, 2022
Mixing drugs, also known as polysubstance use, occurs when two or more drugs are taken together or within a short time period, intentionally or unintentionally. Even if someone has mixed drugs before, or mixes drugs often...
Polysubstance Use Facts
What is polysubstance use?
The use of more than one drug, also known as polysubstance use, is common. This includes when two or more are taken together or within a short time period, either intentionally or unintentionally.
Intentional...
FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention
Abstract
Substance use disorders (SUDs) are highly prevalent and impact individuals' health, well-being, and social functioning. Long-lasting changes in brain networks involved in reward, executive function, stress reactivity, mood, and...
Strategies to Address Cocaine and Methamphetamine
Presented by Richard Rawson, PhD, Emeritus Professor in the Department of Psychiatry and Biobehavioral Science, UCLA School of Medicine and a Research Professor at the University of Vermont, this presentation provided an overview of the...
UNODC supported delegations from four Central Asian countries in a high-level study tour to the United Kingdom
The UNODC Regional Office for Central Asia (ROCA) together with the UNODC Prevention, Treatment and Rehabilitation Section (PTRS) organized a study tour for high-level representatives, including senior officials, policymakers and substance...
72º Regular Session of the Inter-American Drug Abuse Control Comission was held
In the magazine CIJ Informa, the participation of CIJ, host chapter institution of ISSUP Mexico, in the 71st Regular Session of CICAD is reviewed.
The Anti-Stigma Network
The Anti-Stigma Network has been launched!
The Mission
The Anti-Stigma Network has been created by a group of organisations coming together with a shared mission.
Collectively they aim to improve understanding of the stigma and...
Buprenorphine versus methadone for the treatment of opioid dependence
Summary
Background
Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and...